» Articles » PMID: 39691710

Integrating Omics Data and Machine Learning Techniques for Precision Detection of Oral Squamous Cell Carcinoma: Evaluating Single Biomarkers

Overview
Journal Front Immunol
Date 2024 Dec 18
PMID 39691710
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Early detection of oral squamous cell carcinoma (OSCC) is critical for improving clinical outcomes. Precision diagnostics integrating metabolomics and machine learning offer promising non-invasive solutions for identifying tumor-derived biomarkers.

Methods: We analyzed a multicenter public dataset comprising 61 OSCC patients and 61 healthy controls. Plasma metabolomics data were processed to extract 29 numerical and 47 ratio features. The Extra Trees (ET) algorithm was applied for feature selection, and the TabPFN model was used for classification and prediction.

Results: The model achieved an area under the curve (AUC) of 93% and an overall accuracy of 76.6% when using top-ranked individual biomarkers. Key metabolic features significantly differentiated OSCC patients from healthy controls, providing a detailed metabolic fingerprint of the disease.

Discussion: Our findings demonstrate the utility of integrating omics data with advanced machine learning techniques to develop accurate, non-invasive diagnostic tools for OSCC. The study highlights actionable metabolic signatures that have potential applications in personalized therapeutics and early intervention strategies.

References
1.
Ran R, Zhong X, Yang Y, Tang X, Shi M, Jiang X . Metabolomic profiling identifies hair as a robust biological sample for identifying women with cervical cancer. Med Oncol. 2023; 40(2):75. DOI: 10.1007/s12032-022-01848-z. View

2.
Graf E, Pancholi P . Appropriate Use and Future Directions of Molecular Diagnostic Testing. Curr Infect Dis Rep. 2020; 22(2):5. PMC: 7088562. DOI: 10.1007/s11908-020-0714-5. View

3.
Indiveri C, Iacobazzi V, Tonazzi A, Giangregorio N, Infantino V, Convertini P . The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology. Mol Aspects Med. 2011; 32(4-6):223-33. DOI: 10.1016/j.mam.2011.10.008. View

4.
Hasegawa T, Yatagai N, Furukawa T, Wakui E, Saito I, Takeda D . The prospective evaluation and risk factors of dysphagia after surgery in patients with oral cancer. J Otolaryngol Head Neck Surg. 2021; 50(1):4. PMC: 7830751. DOI: 10.1186/s40463-020-00479-6. View

5.
Yang W, Zhou W, Zhao X, Wang X, Duan L, Li Y . Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis. Hereditas. 2021; 158(1):15. PMC: 8066950. DOI: 10.1186/s41065-021-00181-1. View